Why the study?
Does TAVI reduce all-cause mortality compared to SAVR in patients requiring aortic valve replacement?
Does TAVI reduce all-cause mortality compared to SAVR in patients requiring aortic valve replacement?
Answers are grounded in this paper and cite their sources.
A meta-analysis of randomized trials demonstrates a significant reduction in all-cause mortality with TAVI compared to SAVR at up to 2 years of follow-up.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Pilgrim et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: